These data demonstrated that in addition to p110α, β, and γ, rhabdomyosarcoma cells expressed the PI3K p110δ isoform, and cell proliferation could be impaired by targeting this PI3K isoform with the p110δ-specific inhibitor, Idelalisib (CAL-101). This evidence concerns the gene PIK3CA and rhabdomyosarcoma.